Shao, F., Li, Y., & Zhao, Y. (2023). Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: A meta-analysis. Frontiers in endocrinology (Lausanne), 14, 1139858. https://doi.org/10.3389/fendo.2023.1139858
Chicago Style (17th ed.) CitationShao, Fengping, Yinguang Li, and Yunhe Zhao. "Progestin Plus Metformin Improves Outcomes in Patients with Endometrial Hyperplasia and Early Endometrial Cancer More than Progestin Alone: A Meta-analysis." Frontiers in Endocrinology (Lausanne) 14 (2023): 1139858. https://doi.org/10.3389/fendo.2023.1139858.
MLA (9th ed.) CitationShao, Fengping, et al. "Progestin Plus Metformin Improves Outcomes in Patients with Endometrial Hyperplasia and Early Endometrial Cancer More than Progestin Alone: A Meta-analysis." Frontiers in Endocrinology (Lausanne), vol. 14, 2023, p. 1139858, https://doi.org/10.3389/fendo.2023.1139858.